I am Niranjan Ghatule, a B.Tech graduate in Electrical Engineering with a strong passion for the financial markets. With over 5 years of hands-on experience in the stock market, I have developed deep expertise in equity research, market analysis, and trading strategies.
Posts by Niranjan Ghatule:
Jio Financial Services has entered the income tax filing market in partnership with TaxBuddy, offering ITR filing through its app starting at just ₹24. The service aims to make tax filing affordable, providing both self-filing and expert-assisted options, along with tools for tax regime comparison, deductions, and future tax planning. This move expands JFS’s growing presence across multiple financ
India’s retail inflation dropped to 1.55% in July 2025, its lowest since June 2017, with food inflation plunging to -1.76%. Rural and urban inflation eased sharply, driven by falling prices of pulses, cereals, vegetables, and other key commodities. State-wise data shows wide variation, while core categories like health and education remain elevated.
Warren Buffett has fallen out of the world’s top 10 richest people for the first time in years, slipping to 11th place with a $140 billion net worth. Michael Dell, CEO of Dell Technologies, has overtaken him with $141 billion. The updated Bloomberg Billionaires Index also shows major shifts, including Bill Gates’ exit from the list and Elon Musk retaining the top spot.
US President Donald Trump has extended 90-day tariff relief for China amid trade talks on rare earths and chips, while keeping heavy 50% duties on India over Russian oil imports.
Reliance Jio has created history by overtaking China Mobile to become the world’s largest telecom operator with 488 million subscribers, including 190 million 5G users. In just eight years since its 2016 launch, Jio has transformed India’s telecom sector, achieved record 5G rollout, and stunned China’s long-dominant telecom giants.
Iran’s Ambassador to India, Iraj Elahi, launched a sharp attack on the United States from New Delhi, accusing Washington of hypocrisy over Ukraine and Gaza, defending India’s independent foreign policy, and directly targeting Donald Trump’s trade tariffs. The statement, made on Indian soil, is seen as a major geopolitical setback for the US and a boost to India’s image as a non-aligned global powe
Tata Motors shares gain after Q1 results as market factors in past negatives. JLR margins drop but outlook remains strong, debt reduces sharply, CV business stays resilient, and October demerger expected to unlock value.
India’s Ministry of External Affairs has slammed Pakistani Army Chief General Asim Munir over his reported nuclear threat during a US visit, calling it “irresponsible” and “nuclear sabre-rattling.” The MEA said such remarks reinforce doubts about Pakistan’s nuclear control integrity and vowed India will not bow to nuclear blackmail.
Quant Small Cap Fund’s July 2025 portfolio reveals fresh entries in Anthem Biosciences, Marathon Nextgen Realty, and Gland Pharma, major stake hikes in small-cap stocks, and complete exits from Aadhar Housing Finance and Chambal Fertilizers, even as NAV falls 6.53% YoY and AUM drops ₹166 crore.
A viral claim of 3.3 lakh tonnes of gold found in Jabalpur has taken social media by storm, but the truth is far more complex. This article uncovers the real Geological Survey of India findings, explains gold-bearing ore, assesses India’s economic gains if viable, and outlines the environmental, technical, and social challenges before mining can begin.
PG Electroplast Limited (PGEL) shares hit a 10% lower circuit after the company sharply cut its FY26 revenue, PAT, and product business growth guidance. The flagship PG Group firm, a leading Indian electronic manufacturing service provider, revised its outlook amid business challenges. Here’s a detailed look at the guidance cuts, business segments, clientele, manufacturing presence, and June 2025
US-India relations face new strain as Donald Trump threatens a record 250% tariff on Indian medicines, risking higher drug prices in the US. India eyes Russia’s $45B pharma market as an alternative, while China backs New Delhi in a rare move.
